Sonrotoclax
Small Molecule
Overview
Sonrotoclax is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5314951).
Patent & exclusivity (US)
Per the FDA Orange Book (4 approved US products), the latest listed US patent on Sonrotoclax expires 29 Apr 2039 and exclusivity 13 May 2031. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.